TEXAS HEALTH DALLAS — History
CCN 450462 | 3-year financial timeline | COVID resilience: 84/100
🛡️ Public data only — no PHI permitted on this instance.
$711M
Latest Revenue (FY2022)
+13.2%
Revenue CAGR (3yr)
-1.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $554M | $664M | $711M | +7.1% | +13.2% |
| Operating Expenses | $651M | $644M | $724M | +12.5% | +5.5% |
| Operating Margin | -17.4% | 3.0% | -1.9% | -163.6% | +0.0% |
| Net Income | $-96M | $20M | $-14M | -168.1% | +0.0% |
| Licensed Beds | 549 | 531 | 558 | +5.1% | +0.8% |
| Total Patient Days | 124,120 | 140,500 | 136,357 | -2.9% | +4.8% |
| Medicare Day % | 24% | 23% | 24% | +5.2% | -0.1% |
| Medicaid Day % | 3% | 3% | 3% | +8.2% | +4.1% |
COVID Impact & Recovery
Resilience Score: 84/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +28.2% ($554M → $711M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+13.2%
This Hospital
+7.6%
State Avg
Latest Margin
-1.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $789M | 5.8% |
| FY2024 (proj) | $867M | 13.5% |
| FY2025 (proj) | $945M | 21.2% |